Artwork

Sisällön tarjoaa Office of the Vice-Dean Research, College of Medicine, University of Saskatchewan., University of Saskatchewan, OVDR, and College of Medicine. Office of the Vice-Dean Research, College of Medicine, University of Saskatchewan., University of Saskatchewan, OVDR, and College of Medicine tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
Player FM - Podcast-sovellus
Siirry offline-tilaan Player FM avulla!

Triple Negative Breast Cancer: Chandra Dattani's Story

27:09
 
Jaa
 

Manage episode 326440966 series 2876289
Sisällön tarjoaa Office of the Vice-Dean Research, College of Medicine, University of Saskatchewan., University of Saskatchewan, OVDR, and College of Medicine. Office of the Vice-Dean Research, College of Medicine, University of Saskatchewan., University of Saskatchewan, OVDR, and College of Medicine tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.

Chandra Dattani's smile lit up the room, and her laughter was contagious.

But when the beloved Saskatoon businesswoman and volunteer was diagnosed with triple negative breast cancer, even her husband, a physician, found very little information about therapies or drugs that could heal her.

"There was very scant literature on triple negative, and I was asking them, why?" said Dr. Dan Dattani.

Typically, oncology teams target estrogen and progesterone receptors to stop breast cancer tumours from growing and spreading.

Unfortunately, those targets don't work for the 15 to 20 per cent of breast cancer patients with triple negative breast cancer, a swift-moving and aggressive form of the disease.

Still, Chandra Dattani and her family decided to fight back.

They established the Chandra Dattani Memorial Fund in 2010. It's currently endowed with a balance of over 120 thousand dollars, and continues to support critical cancer research on an annual basis.

"She was so dedicated to making sure we'd never gave up on ourselves and was really our biggest cheerleader every step of the way," said Seema Jain, Dattani's eldest daugher.

In this episode, Jain joins her siblings and her father in unraveling her mother's story, and pushing for more research and therapies dedicated to women with a triple negative diagnosis.

"Our biggest hope is hopefully women won't have to suffer the way our mom did," said Dr. Sheev Dattani.

"Hopefully there will be better treatments coming down the road."

  continue reading

80 jaksoa

Artwork
iconJaa
 
Manage episode 326440966 series 2876289
Sisällön tarjoaa Office of the Vice-Dean Research, College of Medicine, University of Saskatchewan., University of Saskatchewan, OVDR, and College of Medicine. Office of the Vice-Dean Research, College of Medicine, University of Saskatchewan., University of Saskatchewan, OVDR, and College of Medicine tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.

Chandra Dattani's smile lit up the room, and her laughter was contagious.

But when the beloved Saskatoon businesswoman and volunteer was diagnosed with triple negative breast cancer, even her husband, a physician, found very little information about therapies or drugs that could heal her.

"There was very scant literature on triple negative, and I was asking them, why?" said Dr. Dan Dattani.

Typically, oncology teams target estrogen and progesterone receptors to stop breast cancer tumours from growing and spreading.

Unfortunately, those targets don't work for the 15 to 20 per cent of breast cancer patients with triple negative breast cancer, a swift-moving and aggressive form of the disease.

Still, Chandra Dattani and her family decided to fight back.

They established the Chandra Dattani Memorial Fund in 2010. It's currently endowed with a balance of over 120 thousand dollars, and continues to support critical cancer research on an annual basis.

"She was so dedicated to making sure we'd never gave up on ourselves and was really our biggest cheerleader every step of the way," said Seema Jain, Dattani's eldest daugher.

In this episode, Jain joins her siblings and her father in unraveling her mother's story, and pushing for more research and therapies dedicated to women with a triple negative diagnosis.

"Our biggest hope is hopefully women won't have to suffer the way our mom did," said Dr. Sheev Dattani.

"Hopefully there will be better treatments coming down the road."

  continue reading

80 jaksoa

Kaikki jaksot

×
 
Loading …

Tervetuloa Player FM:n!

Player FM skannaa verkkoa löytääkseen korkealaatuisia podcasteja, joista voit nauttia juuri nyt. Se on paras podcast-sovellus ja toimii Androidilla, iPhonela, ja verkossa. Rekisteröidy sykronoidaksesi tilaukset laitteiden välillä.

 

Pikakäyttöopas